KDR and glioblastoma: Liu et al. demonstrated that the platelet-derived growth factor (PDGF) signaling pathway mediates the EndoMT process in tumor-derived ECs in GBM, mainly downregulating the VEGFR-2 expression and inducing resistance to anti-angiogenic treatment [126].